209 related articles for article (PubMed ID: 8674964)
21. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
22. Antileprosy drugs, pregnancy and fetal outcome.
Bhargava P; Kuldeep CM; Mathur NK
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
[No Abstract] [Full Text] [Related]
23. Study of multidrug therapy in paucibacillary leprosy.
Kar PK; Sohi AS
J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
[TBL] [Abstract][Full Text] [Related]
24. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
25. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
26. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
27. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
Shetty VP; Wakade A; Antia NH
Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
[No Abstract] [Full Text] [Related]
28. Serious side effects of rifampin on the course of WHO/MDT: a case report.
Namisato M; Ogawa H
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):277-82. PubMed ID: 11221090
[TBL] [Abstract][Full Text] [Related]
29. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
[TBL] [Abstract][Full Text] [Related]
30. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
31. A case of isolated tuberculoid leprosy of antebrachial medial cutaneous nerve.
Martins RS; Siqueira MG; Carvalho AA
Neurol Sci; 2004 Oct; 25(4):216-9. PubMed ID: 15549507
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
33. Response of leprosy patients with single lesions to MDT.
Katoch K; Natrajan M; Yadav VS; Bhatia AS
Acta Leprol; 1995; 9(3):133-7. PubMed ID: 7631584
[TBL] [Abstract][Full Text] [Related]
34. Criteria for diagnosis of pure neural leprosy.
Jardim MR; Antunes SL; Santos AR; Nascimento OJ; Nery JA; Sales AM; Illarramendi X; Duppre N; Chimelli L; Sampaio EP; Sarno EP
J Neurol; 2003 Jul; 250(7):806-9. PubMed ID: 12883921
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic prospects for paucibacillary leprosy.
Katoch K
Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
[No Abstract] [Full Text] [Related]
36. Dapsone syndrome: an incomplete form.
Jaswal R; Thami GP; Kanwar AJ
Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
[No Abstract] [Full Text] [Related]
37. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
38. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Mendis S; Somasiri KG; Chularatna W
Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
[TBL] [Abstract][Full Text] [Related]
39. Pure neuritic leprosy in India: an appraisal.
Kumar B; Kaur I; Dogra S; Kumaran MS
Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):284-90. PubMed ID: 15485285
[TBL] [Abstract][Full Text] [Related]
40. Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German.
Biedermann T; Degitz K; Schirren CG; Burgdorf W; Plewig G; Bieber T
Br J Dermatol; 1997 Dec; 137(6):1006-10. PubMed ID: 9470925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
